|
Wiener lab, in 1960, started manufacturing reagents applied to diagnostics, and in 1966 began its exports operations. Now devoted to research, development, manufacturing and marketing of reagents for Clinical Chemistry, Blood Bank, Serology, Coagulation, etc. It has an advanced Biotech center where syntetic peptides, monoclonal antibodies, recombinant proteins, antigens, etc. are produced. Current license contracts include the Centers for Disease Control (HBsAg antigens), University of Navarra (Spain), Program for Appropriate Technologies in Health (USA), etc. New technologies for licensing and/or manufacturing welcome.
Activity:
- Licensing & Business Development
- Manufacturing
Product / Technology type(s) covered:
- Bio
- Diagnostics
- Proteins
- Reagents
Therapeutic targets:
|
|